Depression, anxiety disorders such as panic disorder and obsessive-compulsive disorders, alcohol and drug dependence, dementia and Parkinsons disease are just a few examples of disorders of the brain. The size, the burden and cost of brain disorders in the EU is immense, and has so far been underestimated, as Prof. Dr. Hans Ulrich Wittchen emphasized at the Official Press Conference to the 20th ECNP Congress for Neuropsychopharmacology in Vienna (October 13-17, 2007). This week over 6000 psychiatrists, neurologists, psychologists and neuroscience researchers and practitioners from all over the world join in Vienna at the 20th ECNP Congress to present and discuss the latest breakthroughs, the progress and the future perspectives in the fields of the origin and treatment of mental disorders, disorders of the brain, neuropsychopharmacology and related fields.
Increasing Lifetime Risk Unmet Needs
Mental disorders such as anxiety and depressive disorders are disorders of the brain and involve complex patterns of disturbances of cognition (such as perception, attention, memory), affect and emotion (such as depressed mood, panic), somatic functioning (e.g. appetite, heart rate variability) and behaviour. These patterns and disturbances are all associated with disturbances in the transmitter systems of the brain and the central nervous system. What is special about most mental disorders is that they predominantly manifest early in life, before the age of 20. They are also associated across the life span with a high risk of developing complications and other so called comorbid disorders.
Conservatively estimated 27% of the adult EU-population has been suffering from at least
one mental disorder in the past 12 months, such as depression, specific phobias,
somatoform disorders, alcohol- and drug dependence, social phobia,
generalized anxiety disorder (GAD), bipolar disorder, psychotic disord
|Contact: Hans-Ulrich Wittchen|
European College of Neuropsychopharmacology